GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (FRA:BJX1) » Definitions » Cyclically Adjusted Book per Share

BioLife Solutions (FRA:BJX1) Cyclically Adjusted Book per Share : €5.50 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is BioLife Solutions Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BioLife Solutions's adjusted book value per share for the three months ended in Mar. 2025 was €6.860. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.50 for the trailing ten years ended in Mar. 2025.

During the past 12 months, BioLife Solutions's average Cyclically Adjusted Book Growth Rate was 15.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 43.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BioLife Solutions was 121.70% per year. The lowest was -90.70% per year. And the median was -10.10% per year.

As of today (2025-05-29), BioLife Solutions's current stock price is €19.40. BioLife Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €5.50. BioLife Solutions's Cyclically Adjusted PB Ratio of today is 3.53.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BioLife Solutions was 242.89. The lowest was 2.28. And the median was 6.47.


BioLife Solutions Cyclically Adjusted Book per Share Historical Data

The historical data trend for BioLife Solutions's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Cyclically Adjusted Book per Share Chart

BioLife Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 1.61 2.88 4.00 4.91

BioLife Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.12 4.34 4.23 4.91 5.50

Competitive Comparison of BioLife Solutions's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, BioLife Solutions's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLife Solutions's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioLife Solutions's Cyclically Adjusted PB Ratio falls into.


;
;

BioLife Solutions Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioLife Solutions's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=6.86/134.9266*134.9266
=6.860

Current CPI (Mar. 2025) = 134.9266.

BioLife Solutions Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.735 100.684 0.985
201509 0.670 100.392 0.900
201512 0.627 99.792 0.848
201603 0.534 100.470 0.717
201606 0.482 101.688 0.640
201609 0.430 101.861 0.570
201612 0.233 101.863 0.309
201703 0.201 102.862 0.264
201706 0.460 103.349 0.601
201709 0.454 104.136 0.588
201712 0.608 104.011 0.789
201803 0.600 105.290 0.769
201806 1.045 106.317 1.326
201809 2.064 106.507 2.615
201812 0.693 105.998 0.882
201903 2.098 107.251 2.639
201906 2.167 108.070 2.706
201909 3.435 108.329 4.278
201912 1.878 108.420 2.337
202003 2.897 108.902 3.589
202006 3.617 108.767 4.487
202009 4.937 109.815 6.066
202012 5.106 109.897 6.269
202103 5.214 111.754 6.295
202106 9.255 114.631 10.894
202109 10.035 115.734 11.699
202112 10.117 117.630 11.605
202203 10.264 121.301 11.417
202206 9.170 125.017 9.897
202209 9.655 125.227 10.403
202212 8.027 125.222 8.649
202303 7.726 127.348 8.186
202306 7.482 128.729 7.842
202309 7.098 129.860 7.375
202312 6.855 129.419 7.147
202403 6.713 131.776 6.873
202406 6.477 132.554 6.593
202409 6.343 133.029 6.433
202412 7.104 133.157 7.198
202503 6.860 134.927 6.860

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


BioLife Solutions  (FRA:BJX1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioLife Solutions's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=19.40/5.50
=3.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BioLife Solutions was 242.89. The lowest was 2.28. And the median was 6.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BioLife Solutions Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLife Solutions Business Description

Traded in Other Exchanges
Address
3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines